Abstract TP372: Stroke Patients Transported To A Primary Stroke Center More Likely To Receive Intravenous Tissue Plasminogen Activator
Abstract only Background: South Carolina (SC) is located in the “buckle” of the stroke belt with one of the highest stroke death rates in the country. In 2010, SC had 66 acute care hospitals caring for strokes, nine of which were certified primary stroke centers (PSC). The rate of intravenous tissue...
Saved in:
Published in | Stroke (1970) Vol. 44; no. suppl_1 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
01.02.2013
|
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract only
Background:
South Carolina (SC) is located in the “buckle” of the stroke belt with one of the highest stroke death rates in the country. In 2010, SC had 66 acute care hospitals caring for strokes, nine of which were certified primary stroke centers (PSC). The rate of intravenous tissue plasminogen activator (IV-tPA) use and its correlates have not been investigated in the state.
Objectives:
To study the rate of IV-tPA use and its correlates using the statewide hospital discharge records stored at SC Department of Health and Environmental Control (DHEC), for the calendar year 2010.
Methods:
A retrospective analysis was conducted of the statewide hospital discharge records stored at SC DHEC, for the calendar year 2010. Patients with a discharge diagnosis of ischemic stroke were included in the analysis. Variables considered included patient demographics, insurance status, location/type of destination hospital, and treatment with IV-tPA.
Results:
In the calendar year 2010, 10,377 hospitalized patients in SC were assigned a primary discharge diagnosis of ischemic stroke. Of these, 4.2% (442) were treated with IV-tPA. Those who were treated with IV-tPA were younger (mean age ± standard deviation=66.7 ± 14.4, p=0.002) compared with those who did not receive IV-tPA (68.8±13.6). Patients treated at a PSC (49% of all ischemic stroke patients) were more likely to receive IV-tPA (Odds Ratio or OR 4.0, 95% CI 3.2-5.0).Patients treated in hospitals located in urban counties were more likely to receive IV-tPA compared to those treated in rural counties (OR 1.3, 95% CI 1.1-5.3). On multivariate logistic regression analysis, patients treated at a PSC (Adjusted OR 2.2, 95% CI 1.9-2.5) and those treated in urban counties (Adjusted OR 1.4, 95% CI 1.1-1.8) independently increased the likelihood of receiving IV-tPA. Gender, race and insurance status did not significantly change the likelihood of receiving IV-tPA.
Conclusions:
Younger stroke patients, treatment in a PSC and hospitals located in an urban county increased the likelihood of receiving IV-tPA. Increasing community awareness of PSCs, their location and designation may increase the rate of IV-tPA use. |
---|---|
AbstractList | Abstract only
Background:
South Carolina (SC) is located in the “buckle” of the stroke belt with one of the highest stroke death rates in the country. In 2010, SC had 66 acute care hospitals caring for strokes, nine of which were certified primary stroke centers (PSC). The rate of intravenous tissue plasminogen activator (IV-tPA) use and its correlates have not been investigated in the state.
Objectives:
To study the rate of IV-tPA use and its correlates using the statewide hospital discharge records stored at SC Department of Health and Environmental Control (DHEC), for the calendar year 2010.
Methods:
A retrospective analysis was conducted of the statewide hospital discharge records stored at SC DHEC, for the calendar year 2010. Patients with a discharge diagnosis of ischemic stroke were included in the analysis. Variables considered included patient demographics, insurance status, location/type of destination hospital, and treatment with IV-tPA.
Results:
In the calendar year 2010, 10,377 hospitalized patients in SC were assigned a primary discharge diagnosis of ischemic stroke. Of these, 4.2% (442) were treated with IV-tPA. Those who were treated with IV-tPA were younger (mean age ± standard deviation=66.7 ± 14.4, p=0.002) compared with those who did not receive IV-tPA (68.8±13.6). Patients treated at a PSC (49% of all ischemic stroke patients) were more likely to receive IV-tPA (Odds Ratio or OR 4.0, 95% CI 3.2-5.0).Patients treated in hospitals located in urban counties were more likely to receive IV-tPA compared to those treated in rural counties (OR 1.3, 95% CI 1.1-5.3). On multivariate logistic regression analysis, patients treated at a PSC (Adjusted OR 2.2, 95% CI 1.9-2.5) and those treated in urban counties (Adjusted OR 1.4, 95% CI 1.1-1.8) independently increased the likelihood of receiving IV-tPA. Gender, race and insurance status did not significantly change the likelihood of receiving IV-tPA.
Conclusions:
Younger stroke patients, treatment in a PSC and hospitals located in an urban county increased the likelihood of receiving IV-tPA. Increasing community awareness of PSCs, their location and designation may increase the rate of IV-tPA use. |
Author | Hawsey, Kelly Sumner, Roxanne Brown, Jordan Sen, Souvik Kowalczyk, Hannah E Finney, Chris Burdine, Joselyn Heidari, Khosrow |
Author_xml | – sequence: 1 givenname: Souvik surname: Sen fullname: Sen, Souvik organization: USC Sch of Medicine, Columbia, SC – sequence: 2 givenname: Kelly surname: Hawsey fullname: Hawsey, Kelly organization: USC Palmetto Health Stroke Cntr, Columbia, SC – sequence: 3 givenname: Joselyn surname: Burdine fullname: Burdine, Joselyn organization: USC Sch of Medicine, Columbia, SC – sequence: 4 givenname: Hannah E surname: Kowalczyk fullname: Kowalczyk, Hannah E organization: USC Sch of Medicine, Columbia, SC – sequence: 5 givenname: Roxanne surname: Sumner fullname: Sumner, Roxanne organization: USC Sch of Medicine, Columbia, SC – sequence: 6 givenname: Chris surname: Finney fullname: Finney, Chris organization: DHEC, Columbia, SC – sequence: 7 givenname: Jordan surname: Brown fullname: Brown, Jordan organization: DHEC, Columbia, SC – sequence: 8 givenname: Khosrow surname: Heidari fullname: Heidari, Khosrow organization: DHEC, Columbia, SC |
BookMark | eNqdj0FOwzAQRS1UJFLgCEhzgQQ7cUrDLqpAVAIpguwtE6bINLUjjxOpF-DcuLRcgNVs3v9_3pzNrLPI2I3gmRALcUvBZ1JmNA5Dr0RWt01xl5-xRJS5TOUiX85YwnlRpbmsqgs2J_rinOfFskzYd_0e47oL8Ju6h7fg3Rah0cGgDQSt15YG5wN-QOughsabnfb7P3AVKfTw4jzCs9livz9gr9ihmRDWNpZPaN0YmwzRGJt7TTtj3SdaqLtgJh2cv2LnG90TXp_uJSsfH9rVU9p5R-Rxo4bjrBJcHaRV_FpJqU7S6ihd_Df3AwJaal4 |
ContentType | Journal Article |
DBID | AAYXX CITATION |
DOI | 10.1161/str.44.suppl_1.ATP372 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1524-4628 |
ExternalDocumentID | 10_1161_str_44_suppl_1_ATP372 |
GroupedDBID | --- .3C .55 .GJ .XZ .Z2 01R 0R~ 123 1J1 2WC 3O- 40H 4Q1 4Q2 4Q3 53G 5RE 5VS 6PF 71W 77Y 7O~ A9M AAAAV AAAXR AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AAQKA AAQQT AARTV AASCR AASOK AAUEB AAXQO AAYEP AAYJJ AAYXX ABASU ABBUW ABDIG ABJNI ABQRW ABVCZ ABXVJ ABZAD ACCJW ACDDN ACEWG ACGFS ACGOD ACILI ACWDW ACWRI ACXJB ACXNZ ADBBV ADFPA ADGGA ADHPY ADNKB AE3 AE6 AEBDS AEETU AENEX AFDTB AFEXH AFFNX AFSOK AFUWQ AGINI AHMBA AHOMT AHQNM AHRYX AHVBC AIJEX AINUH AJIOK AJNWD AJNYG AJZMW AKULP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AWKKM AYCSE BAWUL BCGUY BOYCO BQLVK BS7 C45 CITATION CS3 DIK DIWNM DU5 DUNZO E.X E3Z EBS EEVPB EJD ERAAH EX3 F2K F2L F2M F2N F5P FCALG FL- FW0 GNXGY GQDEL GX1 H0~ H13 HLJTE HZ~ IKREB IKYAY IN~ IPNFZ J5H JF9 JG8 JK3 JK8 K8S KD2 KMI KQ8 L-C L7B M18 N4W N9A N~7 N~B N~M O9- OAG OAH OB3 OCUKA ODA ODMTH OGROG OHYEH OJAPA OK1 OL1 OLG OLH OLU OLV OLW OLY OLZ OPUJH ORVUJ OUVQU OVD OVDNE OVIDH OVLEI OVOZU OWBYB OWU OWV OWW OWX OWY OWZ OXXIT P-K P2P PQQKQ R58 RAH RHF RIG RLZ S4R S4S T8P TEORI TSPGW TWZ V2I VVN W3M W8F WH7 WOQ WOW X3V X3W X7M XXN XYM YCJ YFH YHZ YQJ YYP ZB8 ZGI ZZMQN |
ID | FETCH-crossref_primary_10_1161_str_44_suppl_1_ATP3723 |
ISSN | 0039-2499 |
IngestDate | Fri Aug 23 01:21:02 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | suppl_1 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-crossref_primary_10_1161_str_44_suppl_1_ATP3723 |
ParticipantIDs | crossref_primary_10_1161_str_44_suppl_1_ATP372 |
PublicationCentury | 2000 |
PublicationDate | 2013-02-00 |
PublicationDateYYYYMMDD | 2013-02-01 |
PublicationDate_xml | – month: 02 year: 2013 text: 2013-02-00 |
PublicationDecade | 2010 |
PublicationTitle | Stroke (1970) |
PublicationYear | 2013 |
SSID | ssj0002385 |
Score | 4.2237144 |
Snippet | Abstract only
Background:
South Carolina (SC) is located in the “buckle” of the stroke belt with one of the highest stroke death rates in the country. In 2010,... |
SourceID | crossref |
SourceType | Aggregation Database |
Title | Abstract TP372: Stroke Patients Transported To A Primary Stroke Center More Likely To Receive Intravenous Tissue Plasminogen Activator |
Volume | 44 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NattAEF7cFEovJWlT2rQJe-gtSLGllWz1JkqDk5CSYhVyE9Z6TY1VKShygvMAfZe-ZWZ2R9YmmFDnIoxYjyV9n0czs_PD2Bc5laGnfOWEQTZxxCToOpGKJs7Al0L2BtNI6Kq08x_h8Jc4vQwuO51_VtbSos5cebe2ruQ5qMI5wBWrZDdAdiUUTsBnwBeOgDAc_wvjOMNAhawPkwu_76FzP6qrcq6w8f5Ml661vcsxYwa0wAV1l6CFGNxVFfyzKwXu-VzlS1wGtqTCjKITjPzemC6uiUYIhxxd_5kVJVzTYSz1bLSysi1cEoz9n6J-1wo0jIyCG5WLm9m8VXy3tHN1pvL8QXHFrFDNFkW-bHMFyttxLu-WWokPx0Ux_k3FFBS6wDESqzQQUsc-bu-YCUmuIg3sCQcLZm0VbVpEEhWvcdxp2luv_0PU__DsXSFcWujGGoT2hdds8j96D66yE7VfFPZSEJMKkZKY1Ih5wV56_SjA7NGzn21jerB8zLAMuiMqFgMxR2uvxjKDLHsm2WZvyBHhsWHVDuuo4i17dU6pFu_Y34ZcXEv6yg2wvKEWt6jFk5LHnKjVLDTU4kgtbqiFy4ha3KIWN9TiFrX4ilq7LDj-nnwbOs19pFfmZ9Inn5__nm0VZaE-MD5VcjCe9IIQXFzRlTIKsHlS1-tnYgp-hPrI3M1k7236hU_sdcvLz2yrrhZqH4zMOjvQ8N4D9VuHzg |
link.rule.ids | 315,786,790,27955,27956 |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Abstract+TP372%3A+Stroke+Patients+Transported+To+A+Primary+Stroke+Center+More+Likely+To+Receive+Intravenous+Tissue+Plasminogen+Activator&rft.jtitle=Stroke+%281970%29&rft.au=Sen%2C+Souvik&rft.au=Hawsey%2C+Kelly&rft.au=Burdine%2C+Joselyn&rft.au=Kowalczyk%2C+Hannah+E&rft.date=2013-02-01&rft.issn=0039-2499&rft.eissn=1524-4628&rft.volume=44&rft.issue=suppl_1&rft_id=info:doi/10.1161%2Fstr.44.suppl_1.ATP372&rft.externalDBID=n%2Fa&rft.externalDocID=10_1161_str_44_suppl_1_ATP372 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0039-2499&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0039-2499&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0039-2499&client=summon |